.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Express Scripts
Queensland Health
Accenture
McKesson
Moodys
UBS
Daiichi Sankyo
Harvard Business School
Colorcon

Generated: June 27, 2017

DrugPatentWatch Database Preview

EMBELINE E Drug Profile

« Back to Dashboard

Which patents cover Embeline E, and when can generic versions of Embeline E launch?

Embeline E is a drug marketed by Hi Tech Pharma and is included in one NDA.

The generic ingredient in EMBELINE E is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

Summary for Tradename: EMBELINE E

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list40
Patent Applications: see list4,888
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EMBELINE E at DailyMed

Pharmacology for Tradename: EMBELINE E

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hi Tech Pharma
EMBELINE E
clobetasol propionate
CREAM;TOPICAL075325-001Dec 24, 1998AB2RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Fish and Richardson
Colorcon
Cipla
Cerilliant
Express Scripts
Mallinckrodt
Accenture
Johnson and Johnson
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot